Assyro is an AI-powered regulatory submission workspace tailored for pharmaceutical, biotechnology, and medical device teams. It streamlines the complex process of drafting, validating, and managing regulatory submissions, enabling organizations to reduce submission cycles by over six weeks and save approximately $250,000 per cycle. By integrating drafting, validation, and audit readiness into a unified platform, Assyro enhances efficiency and compliance across regulatory operations. Key Features and Functionality: - AI-Powered Submission Drafting: Assyro accelerates the creation of regulatory documents by providing intelligent suggestions and clause-level guidance, allowing teams to draft up to three times faster. - Real-Time eCTD Validation: The platform offers real-time validation of Electronic Common Technical Document (eCTD) submissions, identifying errors and compliance issues early to reduce validation time and minimize the risk of rejection. - Centralized Regulatory Intelligence: Users have access to a comprehensive knowledge base of regulatory information, including key documents like CFR Title 21 and regulatory letters, supporting informed decision-making during the submission process. - Audit-Ready Documentation: Assyro automatically generates and maintains detailed, audit-ready trails of all actions and changes, ensuring organized documentation readily available for inspections. - Automated Workflow Management: The system triggers validation, drafting, routing, and readiness checks automatically at critical timeline points, embedding essential checks into the workflow to prevent last-minute issues. Primary Value and User Solutions: Assyro addresses the challenges of time-consuming rework, version control issues, and manual status reporting in regulatory submissions. By automating and integrating key aspects of the submission process, it enables regulatory teams to: - Reduce Submission Timelines: By cutting review cycles from weeks to days and automating workflows, Assyro significantly shortens the time required for regulatory submissions. - Enhance Compliance and Audit Readiness: The platform ensures that all submissions are audit-ready, with comprehensive documentation and traceability, aligning with regulatory standards such as 21 CFR Part 11 and EU Annex 11. - Increase Operational Efficiency: Assyro allows teams to manage multiple programs across jurisdictions without expanding headcount, providing consistent execution and coordination across affiliates and partners. By leveraging Assyro, organizations can streamline their regulatory submission processes, reduce costs, and improve compliance, ultimately accelerating the time-to-market for their products.